Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A non-pharmaceutical **combination dietary supplement** composed of **ginseng** (commonly Panax ginseng) and **branched-chain amino acids** (BCAAs: leucine, isoleucine, and valine). This combination is primarily marketed and studied for its potential to improve exercise performance, reduce central fatigue, and enhance attention during strenuous activity. Mechanistically, BCAAs are believed to promote muscle protein synthesis and reduce muscle breakdown, likely through the mTOR pathway, while ginseng is attributed with adaptogenic properties and potential to enhance cognitive function, modulate fatigue, and support physical endurance. There is evidence from at least one placebo-controlled clinical trial suggesting the combination may improve attentional performance and subjective fatigue in the context of exercise[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginseng + branched-chain amino acids.